SCHEMBL9819142

SCHEMBL9819142

O=C(C=Cc1cc(F)ccc1O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 2/20 0.64
▸ TYR P14679 1/20 0.60
▸ MAOB P27338 3/20 0.57
▸ MAPT P10636 3/20 0.53
▸ LMNA P02545 2/20 0.53
▸ BCHE P06276 2/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ GABRA3 P34903 1/20 0.52
▸ GABRA2 P47869 1/20 0.52
▸ GABRB2 P47870 1/20 0.52
▸ PLIN1 O60240 1/20 0.51
▸ TNFRSF1A P19438 1/20 0.51
▸ ACHE P22303 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ PLIN5 Q00G26 1/20 0.51
▸ CYP1B1 Q16678 1/20 0.51
▸ ABHD5 Q8WTS1 1/20 0.51
▸ CAPN1 P07384 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9819136 1.00 AR (0.64) ARTYRMAOBMAPTLMNA
SCHEMBL29837087 1.00 AR (0.64) ARTYRMAOBMAPTLMNA
SCHEMBL1659468 0.85 TYR (0.77) TYRMAOBMAPTRAB9ACYP1B1
SCHEMBL1659465 0.85 TYR (0.77) TYRMAOBMAPTRAB9ACYP1B1
SCHEMBL13776889 0.85 NFE2L2 (0.56) ARTYRMAOBMAPTLMNA
SCHEMBL10341663 0.84 TYR (0.60) TYRMAOBMAPTLMNABCHE
SCHEMBL10341664 0.84 TYR (0.60) TYRMAOBMAPTLMNABCHE
SCHEMBL27940683 0.84 CYP1B1 (0.69) TYRMAOBMAPTLMNABCHE
SCHEMBL3598076 0.83 APP (0.64) ARMAPTLMNACYP1B1CAPN1
SCHEMBL3598073 0.83 APP (0.64) ARMAPTLMNACYP1B1CAPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114890975-B Compound with fused ring chroman structure and preparation method thereof 合肥工业大学 2023-07-18 — — CN claimed
EP-0230379-B1 CHROMAN- AND THIOCHROMAN-4-ACETIC ACIDS USEFUL IN THE TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1991-04-03 — — EP disclosed
US-4853410-A Hydroxyacetic acid derivatives for the treatment of diabetic complications PFIZER INC. (US) 1989-08-01 — — US disclosed
WO-1987004344-A1 HYDROXYACETIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1987-07-30 — — WO disclosed
EP-0230379-A2 Chroman- and thiochroman-4-acetic acids useful in the treatment of diabetic complications PFIZER INC. (US) 1987-07-29 — — EP disclosed
Send feedback